The first patient received a Russian personalized cancer vaccine

For the first time, doctors at the Russian Ministry of Health's NMIC of Radiology injected a patient with the Russian antitumor mRNA vaccine "Neonkovak". This was reported to Izvestia on April 1 by the press service of the Ministry of Health of the Russian Federation.

The first participant in the clinical practice was a 60-year-old resident of the Kursk region suffering from skin melanoma. At the moment, the man is undergoing immunotherapy under the supervision of specialists.

The drug "Neoonkovak" is designed specifically for the treatment of adult patients with inoperable or metastatic melanoma. According to Academician of the Russian Academy of Sciences Andrey Kaprin, this is a fundamentally new method that allows you to "train" the immune system to recognize and attack specific tumor cells that threaten the life of a particular person. The clinical implementation of the technology has been completed.

Health is more expensive than wealth: The Ministry of Health will make cancer vaccines free

Injections complement standard therapy, forming a comprehensive approach to cancer treatment.

Alexander Gintsburg, Scientific Director of the N.F. Gamalei National Research Center for Epidemiology and Microbiology (NITSEM) of the Russian Ministry of Health, said on January 3 that the effectiveness of the Russian vaccine for the treatment of melanoma is more than 90%.

All important news is on the Izvestia channel in the MAX messenger.